In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.

As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and reduce cravings and hunger. But in the UK, it’s only supposed to be used for type 2 diabetes, and that’s in order to try and protect the resources for the type 2 diabetics.”

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO).

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts. But a new study involving more than 54,